ly3298176 tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study Eli Lilly's GIP/GLP-1 dual agonist
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20


32260-8/asset/49a02715-866b-43be-818a-fd87392a76a5/main.assets/gr2_lrg.jpg)
























